Prospera Financial Services
JBIO icon

Prospera Financial Services’s Jade Biosciences JBIO Stock Holding History

Prospera Financial Services’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-683
Closed -$39.7K – 1121
2024
Q2 		$39.7K Buy
+683
New +$453K ﹤0.01% 1121

Other funds holding JBIO

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Prospera Financial Services's JBIO Position: Q3 2024 in Review

Prospera Financial Services sold out of Jade Biosciences (JBIO) in Q3 2024, closing a stake of 683 shares — an estimated $39.7K sold.

Prospera Financial Services first reported a position in JBIO in Q2 2024 and held it in 1 quarter. The position peaked at $39.7K in Q2 2024. 72 funds tracked by Wall St. Rank hold JBIO as of Q3 2024.

  • Prospera Financial Services reported no remaining Jade Biosciences position as of Q3 2024 after selling out during the quarter.
  • Prospera Financial Services sold 683 Jade Biosciences shares in Q3 2024, an estimated $39.7K.
  • Prospera Financial Services first reported a position in Jade Biosciences in Q2 2024 and held it in 1 quarter.
  • Prospera Financial Services's Jade Biosciences position peaked at $39.7K in Q2 2024.
  • 72 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2024.

Based on Prospera Financial Services's 13F filing for Q3 2024, filed 7 Nov 2024.